Headache and the eye

Current Opinion in Ophthalmology

Volumn 20, Issue 6, 2009, Pages 520-524

  Dafera, Rima M ^a   Jay, Walter M ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Headache; Migraine; Ophthalmoplegia; Trigeminal autonomic cephalalgia

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIURETIC AGENT; ERGOT ALKALOID; GABAPENTIN; INDOMETACIN; LAMOTRIGINE; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PREGABALIN; RITUXIMAB; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL;

CLUSTER HEADACHE; DIPLOPIA; DISEASE CLASSIFICATION; EYE PAIN; HEMICRANIA CONTINUA; HORNER SYNDROME; HUMAN; HYPOPHYSIS APOPLEXY; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; MIGRAINE; MIGRAINE AURA; OPHTHALMOPLEGIC MIGRAINE; OPTIC NEURITIS; ORBIT PSEUDOTUMOR; OXYGEN THERAPY; PAROXYSMAL HEMICRANIA; PRIMARY HEADACHE; PRIORITY JOURNAL; RETINAL MIGRAINE; REVIEW; SUNCT SYNDROME; TOLOSA HUNT SYNDROME; TRIGEMINAL AUTONOMIC CEPHALALGIA; VISUAL DISORDER;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; MIGRAINE DISORDERS; TRIGEMINAL AUTONOMIC CEPHALALGIAS; VISION DISORDERS;

EID: 74249102182     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328331270d     Document Type: Review

References (45)

1. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 2004; 24 (Suppl 1):9-160.
2. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005; 45 (Suppl 1):S3-S13.
3. Evans RW, Grosberg BM. Retinal migraine: migraine associated with monocular visual symptoms. Headache 2008; 48:142-145.
4. Pradhan S, Chung SM. Retinal, ophthalmic, or ocular migraine. Curr Neurol Neurosci Rep 2004; 4:391-397.
5. Grosberg BM, Solomon S, Friedman DI, Lipton RB. Retinal migraine reappraised. Cephalalgia 2006; 26:1275-1286.
6. Grosberg BM, Solomon S, Lipton RB. Retinal migraine. Curr Pain Headache Rep 2005; 9:268-271.
7. Kaniecki RG. Basilar-type migraine. Curr Pain Headache Rep 2009; 13:217-220.
8. Kuhn WF, Kuhn SC, Daylida L. Basilar migraine. Eur J Emerg Med 1997; 4:33-38.
9. Dutch Society for Pediatrics. Scientific Meeting of 14 April 1978. Ned Tijdschr Geneeskd 1978; 122:1590-1592.
10. Bek S, Genc G, Demirkaya S, Eroglu E, et al. Ophthalmoplegic migraine. Neurologist 2009; 15:147-149.
11. Goadsby PJ. Pathophysiology of migraine. Neurol Clin 2009; 27:335-360. This study discusses the pathophysiology of migraine.
12. Buzzi MG, Moskowitz MA. The pathophysiology of migraine: year 2005. J Headache Pain 2005; 6:105-111.
13. Goadsby PJ. Migraine pathophysiology. Headache 2005; 45 (Suppl 1):S14-S24.
14. Goadsby PJ, Cittadini E, Burns B, Cohen AS. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol 2008; 21:323-330. This study discusses the clinical features, pathophysiology, and treatment options of trigeminal autonomic cephalalgias.
15. Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002; 1:251-257.
16. Williams MH, Broadley SA. SUNCT and SUNA: clinical features and medical treatment. J Clin Neurosci 2008; 15:526-534.
17. Favier I, van Vliet JA, Roon KI, et al. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol 2007; 64:25-31.
18. Rozen TD. Resolution of SUNCT after removal of a pituitary adenoma in mild acromegaly. Neurology 2006; 67:724.
19. Matharu MS, Levy MJ,Merry RT, Goadsby PJ. SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry 2003; 74:1590-1592.
20. Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol 2003; 10:169-173.
21. Wilbrink LA, Ferrari MD, Kruit MC, Haan J. Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what? Curr Opin Neurol 2009; 22:247-253. This article highlights the importance of neuroimaging in excluding underlying secondary causes for a primary headache disorder.
22. Ito Y, Yamamoto T, Ninomiya M, et al. Secondary SUNCT syndrome caused by viral meningitis. J Neurol 2009; 256:667-668.
23. Adamo MA, Drazin D, Popp AJ. Short-lasting, unilateral neuralgiform headache attacks with conjunctival injection and tearing syndrome treated successfully with transsphenoidal resection of a growth hormone-secreting pituitary adenoma. J Neurosurg 2008; 109:123-125.
24. Gladstone JP. An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome. Curr Pain Headache Rep 2007; 11:317-325.
25. Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye 2006; 20:1196-1206.
26. Kurz PA, Suhler EB, Choi D, Rosenbaum JT. Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol 2009; 93:546-548.
27. Cakirer S. MRI findings in Tolosa-Hunt syndrome before and after systemic corticosteroid therapy. Eur J Radiol 2003; 45:83-90. (Pubitemid 36092128)
28. Colnaghi S, Versino M. Comments on 'Tolosa-Hunt syndrome: MR imaging features in 15 patients with 20 episodes of painful ophthalmoplegia. [Eur J Radiol (2008), doi: 10.1016/j.ejrad.2007.11.034]. Eur J Radiol 2009; 69:193, author reply.
29. Shikishima K, Kitahara K, Inoue K. Ophthalmologic manifestations in headache, neurologic deficits, and cerebrospinal fluid lymphocytosis (HaNDL) syndrome with nonspecific frontal lesions and hyperthyroidism. Eye 2006; 20:613-615.
30. Morrison DG, Phuah HK, Reddy AT, Dure LS, et al. Ophthalmologic involvement in the syndrome of headache, neurologic deficits, and cerebrospinal fluid lymphocytosis. Ophthalmology 2003; 110:115-118.
31. Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 2004; 16:E6.
32. Sjaastad O, Elsas T, Shen JM, Joubert J, et al. Raeder's syndrome: 'anhidrosis', headache, and a proposal for a new classification. Funct Neurol 1994; 9:215-234.
33. Salvesen R. Raeder's syndrome. Cephalalgia 1999; 19 (Suppl 25):42-45.
34. Goadsby PJ. Raeder's syndrome [corrected]: paratrigeminal paralysis of the oculopupillary sympathetic system. J Neurol Neurosurg Psychiatry 2002; 72:297-299.
35. Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 2008; 28:1361-1373.
36. Brazis PW. Pseudotumor cerebri. Curr Neurol Neurosci Rep 2004; 4:111-116.
37. Randhawa S, Van Stavern GP. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Opin Ophthalmol 2008; 19:445-453.
38. Friedman DI. Pseudotumor cerebri presenting as headache. Expert Rev Neurother 2008; 8:397-407.
39. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol 2004; 24:138-145.
40. Lepore FE. The origin of pain in optic neuritis. Determinants of pain in 101 eyes with optic neuritis. Arch Neurol 1991; 48:748-749.
41. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992; 326:581-588.
42. Anninger WV, Lomeo MD, Dingle J, Epstein AD, et al. West Nile virusassociated optic neuritis and chorioretinitis. Am J Ophthalmol 2003; 136: 1183-1185.
43. Athappilly G, Pelak VS, Mandava N, Bennett JL. Ischemic optic neuropathy. Neurol Res 2008; 30:794-800.
44. Obuchowska I, Mariak Z, Budrowski R. Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report. Klin Oczna 2006; 108 (1-3): 124-127.
45. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998; 125:521-526. (Pubitemid 28236920)